Paces Ferry Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Paces Ferry Wealth Advisors's BMY Position: Q2 2026 in Review
Paces Ferry Wealth Advisors reduced its Bristol-Myers Squibb (BMY) stake by 1.8% in Q2 2026, selling an estimated $4.48K and leaving 4,345 shares worth $250K. The position accounts for 0.09% of the portfolio, ranked #117.
Paces Ferry Wealth Advisors first reported a position in BMY in Q3 2020 and has held it in 7 quarters since. The position peaked at $293K in Q1 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Paces Ferry Wealth Advisors held 4,345 shares of Bristol-Myers Squibb worth $250K as of Q2 2026.
- Paces Ferry Wealth Advisors sold 78 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.48K.
- Bristol-Myers Squibb made up 0.09% of Paces Ferry Wealth Advisors's portfolio in Q2 2026, its #117 holding.
- Paces Ferry Wealth Advisors first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 7 quarters since.
- Paces Ferry Wealth Advisors's Bristol-Myers Squibb position peaked at $293K in Q1 2025.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Paces Ferry Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.